PDF-Datei zum Ausdrucken - Paton - TU Ilmenau

16.5 Dokument aus IMSPATENTS
Anzeigeformat: ALL
88
Leitfaden zu STN-Patentdatenbanken
AN 1996:6171 IMSPATENTS
DN 39046 (Country Drug Key)
FN 1883 (Drug Family Key)
SO Patents International, (28 Jan 2008)
OS IMSRESEARCH 1993:604
ED Entered STN: 18 Dec 1996
Last Updated on STN: 18 Dec 1996
CN Generic Name: lanreotide
RE pINN
CN Lab Code: BIM 23014; DC 13116; BIM 23014C; BN 52030
CN Trade Name: SOMATULINE; ANGIOPEPTIN; DERMOPEPTIN; IPSTYL SOMATULINE PR;
SOMATULINE PR; SOMATULINE AUTOGEL; SOMATULINE DEPOT
CN 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl
-L-valyl-L-cysteinyl-L-threoninamide cyclic (2,7)-disulfide
RN 108736-35-2
STR
(CH2)4 NH2
O
H O
N
CH2
HN
RN Derivative(s): 108736-35-2 lanreotide, BIM 23014
118992-92-0 replaced by 108736-35-2
123369-01-7 replaced by 108736-35-2
127984-74-1 acetate, BIM 23014C
CC L2A9 Other cytostatic hormones; H1C2 Antigrowth hormones; S1X Other
Ophthalmologicals; D5B Systemic Antipsoriasis Products; C6A Other
Cardiovascular Products
CT Indication: cancer; solid tumor; endocrine cancer; acromegaly; diabetic
retinopathy; psoriasis; restenosis; cardiovascular disease
Pharmacology: somatostatin analogue
HDP Marketed (80)
PA Tulane University (USA)
CO Tulane University (USA)
ST Method of use
Publication Patent Publication Filing Expiration
Number Type Date Date Date
----------- ---------- ----------- ------- ----------
PI CA 1330037 Granted 19940607 19881118 20110607